Occudo Quantitative Strategies’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Other funds holding ACET
Occudo Quantitative Strategies's ACET Position: Q3 2026 in Review
Occudo Quantitative Strategies reduced its Adicet Bio (ACET) stake by 26% in Q3 2026, selling an estimated $37.7K and leaving 12,310 shares worth $87.9K. The position accounts for 0.01% of the portfolio, ranked #694.
Occudo Quantitative Strategies first reported a position in ACET in Q2 2023 and has held it in 6 quarters since. The position peaked at $349K in Q2 2023. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2026.
- Occudo Quantitative Strategies held 12,310 shares of Adicet Bio worth $87.9K as of Q3 2026.
- Occudo Quantitative Strategies sold 4,326 Adicet Bio shares in Q3 2026, an estimated $37.7K.
- Adicet Bio made up 0.01% of Occudo Quantitative Strategies's portfolio in Q3 2026, its #694 holding.
- Occudo Quantitative Strategies first reported a position in Adicet Bio in Q2 2023 and has held it in 6 quarters since.
- Occudo Quantitative Strategies's Adicet Bio position peaked at $349K in Q2 2023.
- 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.
Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.